Mantra Bio Raises $9 Million in Series A-2 Financing to Advance
https://exosome-rna.com/mantra-bio-raises-9-million-in-series-a-2-financing-to-advance-development-of-lead-targeted-exosome-therapeutics-program/
WEBJan 6, 2023 · Mantra Bio today announced it has raised $9 million in a Series A-2 financing to advance the development of its lead targeted exosome therapeutics program. New investor, Samsung Securities, joined existing investors, including 8VC, Viking Global Investors, Illumina, BoxGroup and Allen & Company in the financing round.
DA: 90 PA: 85 MOZ Rank: 22